Is Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. (BUSE:RICHTER) Trading At A 45% Discount?
Key Insights
- Using the 2 Stage Free Cash Flow to Equity, Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt fair value estimate is Ft14,941
- Current share price of Ft8,220 suggests Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt is potentially 45% undervalued
- Our fair value estimate is 48% higher than Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt's analyst price target of Ft10,123
Does the April share price for Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. (BUSE:RICHTER) reflect what it's really worth? Today, we will estimate the stock's intrinsic value by estimating the company's future cash flows and discounting them to their present value. Our analysis will employ the Discounted Cash Flow (DCF) model. Believe it or not, it's not too difficult to follow, as you'll see from our example!
Companies can be valued in a lot of ways, so we would point out that a DCF is not perfect for every situation. Anyone interested in learning a bit more about intrinsic value should have a read of the Simply Wall St analysis model.
Check out our latest analysis for Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
The Calculation
We are going to use a two-stage DCF model, which, as the name states, takes into account two stages of growth. The first stage is generally a higher growth period which levels off heading towards the terminal value, captured in the second 'steady growth' period. To start off with, we need to estimate the next ten years of cash flows. Where possible we use analyst estimates, but when these aren't available we extrapolate the previous free cash flow (FCF) from the last estimate or reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years.
Generally we assume that a dollar today is more valuable than a dollar in the future, and so the sum of these future cash flows is then discounted to today's value:
10-year free cash flow (FCF) estimate
2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | |
Levered FCF (HUF, Millions) | Ft161.6b | Ft167.9b | Ft197.0b | Ft198.1b | Ft210.4b | Ft219.4b | Ft226.8b | Ft233.0b | Ft238.3b | Ft243.1b |
Growth Rate Estimate Source | Analyst x7 | Analyst x7 | Analyst x7 | Analyst x5 | Analyst x4 | Est @ 4.27% | Est @ 3.37% | Est @ 2.74% | Est @ 2.30% | Est @ 1.99% |
Present Value (HUF, Millions) Discounted @ 8.7% | Ft148.7k | Ft142.2k | Ft153.6k | Ft142.1k | Ft138.9k | Ft133.3k | Ft126.8k | Ft119.9k | Ft112.9k | Ft106.0k |
("Est" = FCF growth rate estimated by Simply Wall St)
Present Value of 10-year Cash Flow (PVCF) = Ft1.3t
The second stage is also known as Terminal Value, this is the business's cash flow after the first stage. The Gordon Growth formula is used to calculate Terminal Value at a future annual growth rate equal to the 5-year average of the 10-year government bond yield of 1.3%. We discount the terminal cash flows to today's value at a cost of equity of 8.7%.
Terminal Value (TV)= FCF2032 × (1 + g) ÷ (r – g) = Ft243b× (1 + 1.3%) ÷ (8.7%– 1.3%) = Ft3.3t
Present Value of Terminal Value (PVTV)= TV / (1 + r)10= Ft3.3t÷ ( 1 + 8.7%)10= Ft1.5t
The total value is the sum of cash flows for the next ten years plus the discounted terminal value, which results in the Total Equity Value, which in this case is Ft2.8t. To get the intrinsic value per share, we divide this by the total number of shares outstanding. Relative to the current share price of Ft8.2k, the company appears quite good value at a 45% discount to where the stock price trades currently. The assumptions in any calculation have a big impact on the valuation, so it is better to view this as a rough estimate, not precise down to the last cent.
Important Assumptions
The calculation above is very dependent on two assumptions. The first is the discount rate and the other is the cash flows. Part of investing is coming up with your own evaluation of a company's future performance, so try the calculation yourself and check your own assumptions. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 8.7%, which is based on a levered beta of 0.800. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business.
SWOT Analysis for Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
- Debt is not viewed as a risk.
- Dividends are covered by earnings and cash flows.
- Earnings growth over the past year underperformed the Pharmaceuticals industry.
- Dividend is low compared to the top 25% of dividend payers in the Pharmaceuticals market.
- Annual earnings are forecast to grow faster than the Hungarian market.
- Trading below our estimate of fair value by more than 20%.
- Revenue is forecast to grow slower than 20% per year.
Moving On:
Valuation is only one side of the coin in terms of building your investment thesis, and it shouldn't be the only metric you look at when researching a company. It's not possible to obtain a foolproof valuation with a DCF model. Rather it should be seen as a guide to "what assumptions need to be true for this stock to be under/overvalued?" If a company grows at a different rate, or if its cost of equity or risk free rate changes sharply, the output can look very different. Why is the intrinsic value higher than the current share price? For Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt, there are three important elements you should consider:
- Risks: Case in point, we've spotted 1 warning sign for Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt you should be aware of.
- Future Earnings: How does RICHTER's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart.
- Other Solid Businesses: Low debt, high returns on equity and good past performance are fundamental to a strong business. Why not explore our interactive list of stocks with solid business fundamentals to see if there are other companies you may not have considered!
PS. The Simply Wall St app conducts a discounted cash flow valuation for every stock on the BUSE every day. If you want to find the calculation for other stocks just search here.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About BUSE:RICHTER
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.
Solid track record with excellent balance sheet and pays a dividend.